CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- 10-Q Report Quarterly Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- NT 10-Q Other NT 10-Q
- UPLOAD Other SEC-generated Letter
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- DEFR14A Other DEFR14A
- 10-Q Report Quarterly Report
- PRER14A Other PRER14A
- 8-K Event Bylaws or fiscal year change
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Director nominations
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure
Page 4 of 31 · 604 filings